We are live on ! Find out more
CNSY

Cerenome

8 hedge funds and large institutions have $717K invested in Cerenome in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.71% less ownership

Funds ownership: 7.97%6.26% (-1.7%)

7% less capital invested

Capital invested by funds: $768K → $717K (-$51K)

20% less funds holding

Funds holding: 108 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

CNSY Hedge Fund Activity: Q1 2021 in Review

8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q1 2021, worth a combined $717K — down 6.6% from $768K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CNSY and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $151K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $214K sold.

  • 8 institutional investors held Cerenome (CNSY) as of Q1 2021, down from 10 in Q4 2020.
  • Funds reported $717K of Cerenome stock for Q1 2021, down 6.6% quarter-over-quarter.
  • 2 funds opened new Cerenome positions in Q1 2021 and 4 closed out, a net change of -2 holders.
  • The largest Cerenome buyer in Q1 2021 was Vanguard Group, an estimated $151K added.
  • The largest Cerenome seller in Q1 2021 was Renaissance Technologies, an estimated $214K sold.

Based on aggregated 13F filings for Q1 2021.